Society for Immunotherapy of Cancer (SITC), shared on LinkedIn:
“In collaboration with the European Society for Medical Oncology, we are pleased to offer a joint Primer program designed to equip attendees with fundamental immuno-oncology concepts!
Join SITC experts Dec. 14 during the 2026 ESMO Immuno-Oncology and Advanced Therapies Congress in London, UK.
We will cover a wide range of topics including:
- Precision immunotherapy: biomarkers of clinical benefit and toxicity risks
- Neoantigen-based cancer immunotherapy
- Cellular therapy of solid tumors
- Myeloid cells in cancer
- Single-cell and spatial biology methodologies
- AI in immuno-oncology drug development
Learn more and register.”
